Open label multicenter study: Efficacy and safety of budesonide / formoterol combination in elderly asthmatic patients.

Not Applicable

• Conditions: bronchial asthma

• Registration Number: JPRN-UMIN000005895
• Lead Sponsor: ational Hospital Organization Matsue Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-09-10
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who used exclusion drugs within previous 4 weeks. 2) Patients who used beta-blockers within previous 4 weeks. 3)Current smoker, smoked within previous 6 months or had smoked more than 10 pack-years in the past. 4)Tachyarrhythmia 5)Patients who are considered inappropriate by physicians in charge.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement of ACQ(asthma control questionnaire) score for 8 weeks using budesonide / formoterol combination

Secondary Outcome Measures

Name	Time	Method
Change of various indicators as follows: 1)Fraction of exhaled Nitric Oxide 2)Asthma relevant QOL (miniAQLQ score) 3)24h Holter ECG (PVC; Premature Ventricular Contraction / heart rate) 4)Blood pressure (SBP / DBP)